These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9493808)

  • 1. Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia.
    Brydak LB; Rokicka-Milewska R; Machała M; Jackowska T; Sikorska-Fic B
    Pediatr Infect Dis J; 1998 Feb; 17(2):125-9. PubMed ID: 9493808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of subunit trivalent influenza vaccine in previously vaccinated children suffering from hemophilia.
    Brydak LB; Rokicka-Milewska R; Machala M; Klukowska A; Laguna P; Sikorska-Fic B
    Clin Microbiol Infect; 1998; 4(10):589-593. PubMed ID: 11864248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults.
    de B; Zanasi A; Ragusa S; Glück R; Herzog C
    Clin Ther; 2002 Jan; 24(1):100-11. PubMed ID: 11833825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland.
    Brydak LB; Rokicka-Milewska R; Jackowska T; Rudnicka H; Regnery H; Cox N
    Leuk Lymphoma; 1997 Jun; 26(1-2):163-9. PubMed ID: 9250801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia.
    Porter CC; Edwards KM; Zhu Y; Frangoul H
    Pediatr Blood Cancer; 2004 Jan; 42(1):36-40. PubMed ID: 14752792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy.
    Shahgholi E; Ehsani MA; Salamati P; Maysamie A; Sotoudeh K; Mokhtariazad T
    Pediatr Blood Cancer; 2010 May; 54(5):716-20. PubMed ID: 20205258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to influenza vaccination in healthy adults.
    Brydak LB; Tadeusz S; Magdalena M
    Viral Immunol; 2004; 17(4):609-15. PubMed ID: 15671759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccination in heart transplant recipients.
    Fraund S; Wagner D; Pethig K; Drescher J; Girgsdies OE; Haverich A
    J Heart Lung Transplant; 1999 Mar; 18(3):220-5. PubMed ID: 10328147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of influenza vaccine in patients with hemato-oncological disorders.
    Brydak LB; Całbecka M
    Leuk Lymphoma; 1999 Jan; 32(3-4):369-74. PubMed ID: 10037036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
    Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
    J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children.
    Zangwill KM; Droge J; Mendelman P; Marcy SM; Partridge S; Chiu CY; Jing J; Chang SJ; Cho I; Ward JI
    Pediatr Infect Dis J; 2001 Aug; 20(8):740-6. PubMed ID: 11734734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people.
    Glathe H; Bigl S; Grosche A
    Vaccine; 1993; 11(7):702-5. PubMed ID: 8342318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    van de Witte S; Nauta J; Montomoli E; Weckx J
    Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.
    Squarcione S; Sgricia S; Biasio LR; Perinetti E
    Vaccine; 2003 Mar; 21(11-12):1268-74. PubMed ID: 12559808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.